Pentraxin-3 modulates hepatocyte ferroptosis and the innate immune response in LPS-induced liver injury
The liver plays a crucial role in the immune response during endotoxemia and is one of the critical targets for sepsis-related injuries. As a secretory factor involved in inflammation, pentraxin-3 (PTX3) has been demonstrated to regulate hepatic homeostasis; however, the relationship between PTX3 and cell crosstalk between immune cells and hepatocytes in the liver remains incompletely understood. In this study, we revealed that, compared with WT mice, Ptx3<sup>-/-</sup> mice with lipopolysaccharide (LPS)-induced endotoxemia exhibited alleviated liver damage, with reduced serum alanine transaminase and aspartate transaminase levels and an improved survival rate. Mechanistically, RNA-Seq and western blot results revealed that Ptx3 knockdown in hepatocytes increased the expression of Tfrc and Ccl20; consequently, Ptx3 deficiency regulated LPS-induced hepatocyte ferroptosis via increased mitochondrial reactive oxygen species and Fe<sup>2+</sup> and recruited more macrophages by CCL20/CCR6 axis to be involved in inflammation and the clearance of harmful substances. Moreover, western blot and immunofluorescence staining confirmed that the NF-κB signaling pathway was upregulated upon LPS treatment in Ptx3-knockdown macrophages, promoting phagocytosis and polarization toward M1 macrophages. Collectively, our findings show that the absence of Ptx3 can ameliorate sepsis-induced liver injury by regulating hepatocyte ferroptosis and promote the recruitment and polarization of M1 macrophages. These findings offer a key basis for the development of effective treatments for acute infections.
Authors
- Linghui Zhan
- Wenbin An
- Zhaojie Su
- Cheng Qiu (ORCID: https://orcid.org/0000-0002-8766-5499)
- H Wang (ORCID: https://orcid.org/0009-0005-3542-1125)
- Baojie Shi (ORCID: https://orcid.org/0000-0001-7783-7149)
- Hao Li (ORCID: https://orcid.org/0000-0002-8151-3830)
- Jiajia Chen (ORCID: https://orcid.org/0000-0003-3659-0658)
- Zhixiang Guo (ORCID: https://orcid.org/0009-0006-1987-2660)
- Ying Wang (ORCID: https://orcid.org/0000-0001-8488-5018)
- Jie Wang (ORCID: https://orcid.org/0000-0001-6051-7245)
- Wei Zeng (ORCID: https://orcid.org/0000-0002-5600-8824)
- Xia Wu (ORCID: https://orcid.org/0000-0002-2761-9976)
- Yi Xiao (ORCID: https://orcid.org/0000-0002-6234-3506)
- Yunyun Qian
- Jianfa Zhong
Institutions
- Xiamen University (CN)
- First Affiliated Hospital of Xiamen University (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Xiamen University of Technology (CN)
Publication Details
- Journal
- Molecular Biomedicine
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1186/s43556-024-00227-6
- Citations
- 10
- Primary Topic
- Biomarkers in Disease Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 2.40
Funders
- Natural Science Foundation of Xiamen City
- National Natural Science Foundation of China
- Distinguished Young Scientific Research Talents Plan in Universities of Fujian Province
- Science Fund for Distinguished Young Scholars of Fujian Province